This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers
by Zacks Equity Research
Butterfly Network targets a 2026 Beam Steering API, opening core imaging to developers and enabling AI tools in Butterfly Garden.
TEM vs. BFLY: Which Stock Offers Greater Upside Amid Health Tech Boom?
by Sridatri Sarkar
Tempus AI posts its first positive adjusted EBITDA while Butterfly Network pushes revenue gains and efficiency in a rapidly evolving health tech market.
BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs
by Zacks Equity Research
Butterfly Network unveils Compass AI to streamline POCUS workflows, boosting documentation compliance and unlocking more revenue for health systems.
BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs
by Zacks Equity Research
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth
by Zacks Equity Research
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
TEM Expands Partnership With Northwestern Medicine Amid AI Boom
by Sridatri Sarkar
Tempus AI deepens its collaboration with Northwestern Medicine, embedding its AI co-pilot David directly into the health system's EHR to boost clinical efficiency.
Zacks.com featured highlights include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network
by Zacks Equity Research
Zacks spotlights five top-ranked stocks including Public Service Enterprise Group and Progressive poised to benefit from rising P/E momentum.
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network.
The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM
by Zacks Equity Research
Butterfly Network and Omnicell stand out as top health-tech stocks benefiting from AI, machine learning, and quantum advancements in healthcare, alongside NVIDIA, Palantir, and IBM driving transformative innovations.
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
by Urmimala Biswas
Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management.